Open an account

Cardinal Health

CAH · NYSE

$257.55+$4.90 (+1.94%)TodayMarket closed ·
Prev close $252.65

About CAH

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 57,700 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The firm also provides pharmaceuticals and medical products. Its segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States, as well as it owns urology MSO. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The firm connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

Employees
57,700
Headquarters
Dublin Ohio, Ohio
Listed
Aug 4, 1983
Sector
Health Care
Industry
Health Care Providers & Services
Website
cardinalhealth.com

CAH key statistics

Market cap
58.50B
Price-earnings ratio
34.94
Dividend yield
0.85%
Average volume
1.79M
Volume
1.02M
Open price
$255.00
High today
$257.55
Low today
$252.36
52 Week high
$258.30
52 Week low
$152.46

Cardinal Health (CAH) at a glance

As of Oct 20, 2026, Cardinal Health (CAH) shares are priced at $257.55, giving the company a market cap of 58.50B, a price-to-earnings ratio of 34.94 and a dividend yield of 0.85%.

Today the stock has traded between $252.36 and $257.55. The current price is 2.1% above the day's low and 0.0% below its high.

Volume so far is 1.02M shares, below the average of 1.79M shares a day.

Over the past year Cardinal Health has ranged from $152.46 to $258.30, and now sits 99% of the way up that range.

Cardinal Health met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $2.60 per share against an estimate of $2.44.

The average analyst price target is $276.94, 7.5% above the current price, from 13 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

92%of 13 analyst ratings say Buy
  • Buy92.3%
  • Hold7.7%
  • Sell0.0%
Price target · 18 analystsAvg $276.94
Low
$242.10
Now
$257.55
High
$306.60

CAH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 7.7% on average.

  1. Q3 FY24: reported $2.08 per share against an estimate of $1.97
  2. Q4 FY24: reported $1.84 per share against an estimate of $1.76
  3. Q1 FY25: reported $1.88 per share against an estimate of $1.63
  4. Q2 FY25: reported $1.93 per share against an estimate of $1.78
  5. Q3 FY25: reported $2.35 per share against an estimate of $2.19
  6. Q4 FY25: reported $2.08 per share against an estimate of $2.06
  7. Q1 FY26: reported $3.17 per share against an estimate of $2.82
  8. Q2 FY26: reported $2.60 per share against an estimate of $2.44

CAH news

  • 10 Health Care Stocks With Whale Alerts In Today’s Session

  • Vandana Singh

    Cardinal Health, McKesson Double Down on CVS Deals Through 2032

  • Press releasePRNewswire

    Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health

  • Press releasePRNewswire

    Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5

  • Vandana Singh

    Cardinal Health Says It Now Exclusively Serves Nearly Half The Cell-And-Gene Therapy Market

  • Avi Kapoor

    US Stocks Mixed; Cardinal Health Shares Jump After Q4 Results

  • Press releasePRNewswire

    Cardinal Health Reports Fourth Quarter and Fiscal Year 2026 Results and Provides Fiscal Year 2027 Guidance

  • Press releasePRNewswire

    Cardinal Health Board of Directors Approves Quarterly Dividend

Similar companies

Companies in the same industry as Cardinal Health

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.